{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:37:43Z","timestamp":1794605863797,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8119","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,6,18]]},"DOI":"10.1038\/s41586-026-10436-4","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:03:09Z","timestamp":1776870189000},"page":"798-805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer"],"prefix":"10.1038","volume":"654","author":[{"given":"Gael","family":"Roth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Artru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Williet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Ghelfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Turpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Lievre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fr\u00e9d\u00e9ric","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3147-1350","authenticated-orcid":false,"given":"Camille","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-286X","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Bachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Manceau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4475-1626","authenticated-orcid":false,"given":"Matthieu","family":"Roustit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2207-8311","authenticated-orcid":false,"given":"Anna","family":"Borowik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoire","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"d\u2019Engremont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea","family":"Chirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Braissand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1614-7755","authenticated-orcid":false,"given":"Nicolas","family":"Rama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0853-1689","authenticated-orcid":false,"given":"Eug\u00e9nie","family":"Modolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6045-2103","authenticated-orcid":false,"given":"Hector","family":"Hernandez-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Georges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1604-6823","authenticated-orcid":false,"given":"Jean-Yves","family":"Scoazec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4935-3865","authenticated-orcid":false,"given":"Jerome","family":"Cros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5740-1188","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Hazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-0508","authenticated-orcid":false,"given":"Benjamin","family":"Ducarouge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Decaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8260-9711","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Bernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1743-5417","authenticated-orcid":false,"given":"Patrick","family":"Mehlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"10436_CR1","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-023-06372-2","volume":"620","author":"J Lengrand","year":"2023","unstructured":"Lengrand, J. et al. Pharmacological targeting of netrin-1 inhibits EMT in cancer. Nature 620, 402\u2013408 (2023).","journal-title":"Nature"},{"key":"10436_CR2","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert, A. W., Pattabiraman, D. R. & Weinberg, R. A. Emerging biological principles of metastasis. Cell 168, 670\u2013691 (2017).","journal-title":"Cell"},{"key":"10436_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ccell.2016.01.001","volume":"29","author":"M Grandin","year":"2016","unstructured":"Grandin, M. et al. Structural decoding of the Netrin-1\/UNC5 interaction and its therapeutical implications in cancers. Cancer Cell 29, 173\u2013185 (2016).","journal-title":"Cancer Cell"},{"key":"10436_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41586-023-06367-z","volume":"620","author":"PA Cassier","year":"2023","unstructured":"Cassier, P. A. et al. Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer. Nature 620, 409\u2013416 (2023).","journal-title":"Nature"},{"key":"10436_CR5","doi-asserted-by":"publisher","unstructured":"Ochiai, Y. et al. Netrin-1 promotes pancreatic tumorigenesis and innervation through NEO1. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-25-2243 (2026).","DOI":"10.1158\/0008-5472.CAN-25-2243"},{"key":"10436_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113369","volume":"42","author":"C Dudgeon","year":"2023","unstructured":"Dudgeon, C. et al. Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and ELF3 signaling. Cell Rep. 42, 113369 (2023).","journal-title":"Cell Rep."},{"key":"10436_CR7","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"10436_CR8","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.3390\/cancers14102417","volume":"14","author":"\u00c1 Sally","year":"2022","unstructured":"Sally, \u00c1, McGowan, R., Finn, K. & Moran, B. M. Current and future therapies for pancreatic ductal adenocarcinoma. Cancers 14, 2417 (2022).","journal-title":"Cancers"},{"key":"10436_CR9","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1245\/s10434-023-13353-2","volume":"30","author":"D Eshmuminov","year":"2023","unstructured":"Eshmuminov, D. et al. FOLFIRINOX or gemcitabine-based chemotherapy for borderline resectable and locally advanced pancreatic cancer: a multi-institutional, patient-level, meta-analysis and systematic review. Ann. Surg. Oncol. 30, 4417\u20134428 (2023).","journal-title":"Ann. Surg. Oncol."},{"key":"10436_CR10","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1001\/jama.2016.4324","volume":"315","author":"P Hammel","year":"2016","unstructured":"Hammel, P. et al. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial. JAMA 315, 1844\u20131853 (2016).","journal-title":"JAMA"},{"key":"10436_CR11","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1200\/JCO-24-02210","volume":"43","author":"M Ducreux","year":"2025","unstructured":"Ducreux, M. et al. PRODIGE 29-UCGI 26 (NEOPAN): A phase III randomized trial comparing chemotherapy with FOLFIRINOX or gemcitabine in locally advanced pancreatic carcinoma. J. Clin. Oncol. 43, 2255\u20132264 (2025).","journal-title":"J. Clin. Oncol."},{"key":"10436_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nrc3005","volume":"11","author":"P Mehlen","year":"2011","unstructured":"Mehlen, P., Delloye-Bourgeois, C. & Ch\u00e9dotal, A. Novel roles for slits and netrins: axon guidance cues as anticancer targets?\u00a0Nat. Rev. Cancer 11, 188\u2013197 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"10436_CR13","volume":"8","author":"M Brisset","year":"2021","unstructured":"Brisset, M., Grandin, M., Bernet, A., Mehlen, P. & Hollande, F. Dependence receptors: new targets for cancer therapy. EMBO Mol. Med. 8, e14495 (2021).","journal-title":"EMBO Mol. Med."},{"key":"10436_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.neuron.2018.12.025","volume":"101","author":"Z Wu","year":"2019","unstructured":"Wu, Z. et al. Long-range guidance of spinal commissural axons by netrin1 and sonic hedgehog from midline floor plate cells. Neuron 101, 635\u2013647.e4 (2019).","journal-title":"Neuron"},{"key":"10436_CR15","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1158\/0008-5472.CAN-18-2952","volume":"79","author":"P-J Sung","year":"2019","unstructured":"Sung, P.-J. et al. Cancer-associated fibroblasts produce netrin-1 to control cancer cell plasticity. Cancer Res. 79, 3651\u20133661 (2019).","journal-title":"Cancer Res."},{"key":"10436_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","volume":"45","author":"NM Aiello","year":"2018","unstructured":"Aiello, N. M. et al. EMT subtype influences epithelial plasticity and mode of cell migration. Dev. Cell 45, 681\u2013695.e4 (2018).","journal-title":"Dev. Cell"},{"key":"10436_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature16064","volume":"527","author":"X Zheng","year":"2015","unstructured":"Zheng, X. et al. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527, 525\u2013530 (2015).","journal-title":"Nature"},{"key":"10436_CR18","doi-asserted-by":"publisher","first-page":"26835","DOI":"10.1073\/pnas.1914915116","volume":"116","author":"RL Porter","year":"2019","unstructured":"Porter, R. L. et al. Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma. Proc. Natl Acad. Sci. USA 116, 26835\u201326845 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10436_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36296-4","volume":"14","author":"G Werba","year":"2023","unstructured":"Werba, G. et al. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nat. Commun. 14, 797 (2023).","journal-title":"Nat. Commun."},{"key":"10436_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","volume":"17","author":"TM Nywening","year":"2016","unstructured":"Nywening, T. M. et al. Phase 1b study targeting tumour associated macrophages with CCR2 inhibition plus FOLFIRINOX in locally advanced and borderline resectable pancreatic cancer. Lancet Oncol. 17, 651\u2013662 (2016).","journal-title":"Lancet Oncol."},{"key":"10436_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1158\/1078-0432.CCR-19-1467","volume":"26","author":"NU Rashid","year":"2020","unstructured":"Rashid, N. U. et al. Purity independent subtyping of tumors (PurIST), a clinically robust, single-sample classifier for tumor subtyping in pancreatic cancer. Clin. Cancer Res. 26, 82\u201392 (2020).","journal-title":"Clin. Cancer Res."},{"key":"10436_CR22","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168\u20131178 (2015).","journal-title":"Nat. Genet."},{"key":"10436_CR23","doi-asserted-by":"publisher","first-page":"105373","DOI":"10.1016\/j.ebiom.2024.105373","volume":"109","author":"R Nicolle","year":"2024","unstructured":"Nicolle, R. et al. Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study. eBioMedicine 109, 105373 (2024).","journal-title":"eBioMedicine"},{"key":"10436_CR24","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1200\/JCO-24-01502","volume":"43","author":"R Fietkau","year":"2025","unstructured":"Fietkau, R. et al. Benefit of chemoradiotherapy versus chemotherapy after induction therapy for conversion of unresectable into resectable pancreatic cancer: the randomized CONKO-007 trial. J. Clin. Oncol. 43, 3266\u20133278 (2025).","journal-title":"J. Clin. Oncol."},{"key":"10436_CR25","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1200\/JCO-25-00746","volume":"43","author":"HM Babiker","year":"2025","unstructured":"Babiker, H. M. et al. Tumor treating fields with gemcitabine and Nab\u2013paclitaxel for locally advanced pancreatic adenocarcinoma: randomized, open-label, pivotal phase III PANOVA-3 study. J. Clin. Oncol. 43, 2350\u20132360 (2025).","journal-title":"J. Clin. Oncol."},{"key":"10436_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-025-01568-9","volume":"17","author":"P Villoslada-Blanco","year":"2025","unstructured":"Villoslada-Blanco, P. et al. Development of a consensus molecular classifier for pancreatic ductal adenocarcinoma. Genome Med. 17, 142 (2025).","journal-title":"Genome Med."},{"key":"10436_CR27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500\u2013503 (2011).","journal-title":"Nat. Med."},{"key":"10436_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352 (2016).","journal-title":"Nature"},{"key":"10436_CR29","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","volume":"155","author":"F Puleo","year":"2018","unstructured":"Puleo, F. et al. Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features. Gastroenterology 155, 1999\u20132013.e3 (2018).","journal-title":"Gastroenterology"},{"key":"10436_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60808-z","volume":"16","author":"JJ Knox","year":"2025","unstructured":"Knox, J. J. et al. Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial. Nat. Commun. 16, 5919 (2025).","journal-title":"Nat. Commun."},{"key":"10436_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"10436_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","volume":"17","author":"TM Nywening","year":"2016","unstructured":"Nywening, T. M. et al. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet Oncol. 17, 651\u2013652 (2016).","journal-title":"Lancet Oncol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10436-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10436-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10436-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T10:24:00Z","timestamp":1781691840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10436-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":32,"journal-issue":{"issue":"8119","published-print":{"date-parts":[[2026,6,18]]}},"alternative-id":["10436"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10436-4","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.R. declares honoraria as consultant and research funding from NETRIS Pharma. A.\u00a0Bernet and P.M. are founders and shareholders of NETRIS Pharma. B.D., E. Georges and S.H. are employees of NETRIS Pharma. The NP137 patent is fully owned by NETRIS Pharma; none of the authors of this study are inventors on this patent. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}